AlloCure Raises $14.5M
Salt Lake City-based AlloCure said Wednesday that the firm has raised $14.5M in a Series A financing round. The round came from SV Life Sciences, which led the round, along with Novo A/S. AlloCure is a biotechnology firm developing therapies for the treatment of acute kidney injury. The firm said the funding would go towards funding its acute kidney disease therapy through Phase II clinical trials, over the next three years.
posted on Wednesday, July 2, 2008 (Link to more information)
Related companies:
AlloCure
Related stories:
> Tendril Raises $15.2M In Funding Round
> Sphero Raises $23M, Aims At $43M In New Funding
> TeamSnap Raises $5.7M In Series B
> Report: TechStars' David Cohen Raises $28M Angel Fund
> Sphero Raises $12.0M, Seeks $20M In New Funding
Techrockies.com Home